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A Hidden Side of Norplant 
by 
Kristine M. Severyn, R.Ph., Ph.D. 
The author received her Ph.D. in biopharmaceutics from the University of 
Cincinnati College of Pharmacy. She is a certified teacher of National Family 
Planning. She lives in Dayton, Ohio with her husband and three children. 
On December 6, 1990 USA Today proclaimed the soon to be licensed 
NORPLANT contraceptive implant, "As perfect a method as you can have."l 
Three years later the Chicago Tribune headline read, "No panacea: Norplant suit 
charges failure to educate patients."2 What happened during this time to dampen 
the initial enthusiasm for Norplant? 
What is Norplant? 
The "NORPLANT SYSTEM" is a birth control method involving the surgical 
insertion of six flexible match stick size rods of Silastic into the inner upper arm of 
women. The rods (implants) contain levonorgestrel, a progesterone type drug, 
which is released slowly to prevent pregnancy for up to five years.3 
Levonorgestrel and its chemical relative norgestrel have been components of 
oral contraceptives ("birth control pills") for several years.4 Since Norplant does 
not contain estrogen, which is associated with blood clotting and cardiovascular 
disorders5,6, the manufacturer promotes Norplant " ... as a particularly good 
option for a woman who ... wants a form of hormonal contraception but does 
not wish to use estrogen-containing contraceptives."7 
How Is Norplant Inserted? 
After the woman lies on the doctor's examining table, and her upper inside 
arm prepared with antispetic, she receives six injections of local anesthetic "to 
mimic the fanlike position of the implanted capsules." Next, a scalpel is used to 
cut a 2mm shallow incision in the woman's arm. Through this incision is inserted 
a large-bore needle, and the six implants placed through this needle under the 
skin in a fan shape. "Correct and carefully performed subdermal insertion of the 
six capsules" is important because "failure to do so may result in deep placement . 
. . and could make removal more difficult." After three days, keeping the wound 
clean and dry, she may resume normal activities. A typical insertion procedure 
takes about fifteen minutes.3 
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What Are the Side Effects of Norplant? 
Nearly all women on Norplant experience changes in menstrual patterns, 
ranging from excessive bleeding, spotting, or total absence of periods. Women 
are warned that this irregular bleeding could "mask symptoms of cervical or 
endometrial cancer." Common adverse reactions during the first year include: 
headache, nervousness, nausea, dizziness, dermatitis (skin inflammation), acne, 
change of appetite, mastalgia (painful breasts), weight gain, hirsutism (excessive 
hair growth), hypertrichosis (facial hair), and scalp hair loss. 
Other Possible adverse reactions include breast discharge, cervicitis 
(inflammation of the cervix), musculoskeletal pain, abdominal discomfort, 
leukorrhea (white vaginal discharge), and vaginitis (vaginal inflammation). 
"Warnings" and "Precautions" include the following: delayed follicular atresia 
(ovarian follicles do not reduce in size after ovulation; may require surgical 
correction); ectopic pregnancy (risk may increase the longer Norplant is used); 
caution ifbreastfeeding; foreign body carcinogenesis (cancer); thromboembolic 
(blood clotting) disorders; caution in smokers; possibility of elevated blood 
pressure; myocardial infarction (heart attack); carcinoma (cancer of the breast, 
uterus, ovaries, or cervix); hepatic (liver) tumors; ocular (eye) lesions; gallbladder 
disease; possible changes in carbohydrate metabolism (may complicate 
diabetes); hyperlipidemia (high blood fat concentration); liver function (jaundice 
may develop); fluid retention; emotional disorders; visual changes with contact 
lenses.3 
Although several or none of the above adverse effects may occur in any 
particular woman, drug company lawyers use similar lists in the manufacturer's 
"Package Insert" as a defense when these companies are sued by recipients of 
drugs or vaccines.8 • and others. 
To stern the high incidence of Norplant side effects 9-11, it was suggested to give 
estrodiol (an estrogen-type drug; 12,13) or oral contraceptivesl4 to reduce the 
duration of excessive bleeding caused by Norplant. It is ironic that Norplant is 
advertised as containing no estrogen, but that estrogen-containing products are 
recommended to remedy Norplant's side effects. 
How Effective Is Norplant? 
Norplant's effectiveness in preventing pregnancy is in the same range as male 
or female sterilization.3 However, this high efficacy (0.2 pregnancies per 100 
women for five years of N orplant use) only applies to women who weigh less than 
110 pounds. For women weighing 110-130 pounds, the five year pregnancy rate 
rises to 3.4 (per 100 women using the method for five years), and to 5.0 for 
women weighing between 131-153 pounds. For larger women (weighing more 
than 154 pounds) the five-year cumulative pregnancy rate rises to 8.5 ,(per 100 
women). Based on these rates the manufacturer is careful to state that Norplant 
provides "up to" five years of contraception.3 
How Does Norplant Prevent Pregnancy? 
Norplant uses several mechanisms to prevent pregnancy. First, the hormone in 
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Norplant inhibits ovulation in about half of cycles, with a trend toward less 
ovulation in the first year of Nor plant use, and more in the later life of the implant 
(cycles inhibited: 20 to 75%15; 59%16; 40 to 86%17; 67%18). In cycles where 
ovulation occurs, less progesterone is produced after ovulation in Norplant 
users I5,16,18 resulting in luteal phase defects, this phase being important for 
implantation of a fertilized ovum, and for the early pregnancy to be maintained. 
Norplant also changes the quality of cervical mucus, making it thick and hostile 
to sperm migration, thereby reducing the possibility that sperm and ovum will 
unite. 16,19 
Last! y, Norplant causes growth of the endometrium (inner lining ofthe uterus) 
to be suppressed, resulting in its inability to support implantation of a fertilized 
ovum, the new human life.20 Although this latter researcher states, "The actual 
role of these endometrial alterations in the overall contraceptive effect of 
Norplant .. . is difficult to assess .. . ," others deny that this abortifacient action 
plays any role in the overall mechanism of Norplant. However they acknowledge 
that an early pregnancy would be easy to miss due to the irregular bleeding 
patterns of Norplant usersl8, or the lack of sensitivity of the blood test used to 
detect hCG during the first five days after fertilization21 (hCG=human chorionic 
gonadotropin; produced by the fertilized ovum in early stages of pregnancy). 
Since pregnancy occurs in a small number of women on NorplantI8,21, it is 
obvious that these back-up contraceptive mechanisms are not always operative. 
Norplant Use In Teens 
Despite the lack of pre-license testing of Norplant in those under 18 years of 
age to determine safety and efficacy in this age group22, teen use of Norplant has 
been advocated.14,23 Planned Parenthood clinics require no parental consent 
before Norplant insertion24, their attorneys determining that when implants are 
inserted through the large-bore needle poked directly through the skin, bypassing 
the small incision, "the procedure is not legally . .. surgery ... and nullifies 
requirements for parental consent".23 
In January 1993 a Baltimore public school for pregnant girls, or girls already 
with babies, began to perform Norplant insertions at its health clinic, with more 
schools expected to follow.25,26 Except for rare dissent based on moral or racial 
objections 27,28, the press has basically supported the policy, with concerns 
expressed only about Norplant's failure to protect users from sexually transmitted 
diseases (STD), including AIDS.29-31 These concerns are valid, based on the high 
rate of gonorrhea infection in teen-age girls as compared to older women.32 
Cost of Norplant 
Norplant can cost up to $700, which includes purchase price of the implant and 
physician charges for insertion and removal. Medicaid pays the cost of Nor plant 
in all fifty states for women on welfare.33 For those not eligible for Medicaid, i.e., 
"working poor," Maryland budgeted $1 million for Norplant and Depo-Provera 
(a 3-month injectable birth control drug), with an unexpected high demand for 
these products during the first three months of the state's program.34 
For indigent women living in other states, Norplant's manufacturer established 
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The Norplant Foundation, described as "a charitable, non-profit foundation 
committed to improving voluntary access to Norplant for American women." 
Eligibility is based on annual income, lack of insurance coverage for 
contraception, and a physician willing to waive the insertion and removal 
fees.35,36 
Although the initial cost of Norplant to U.S. women approaches $700, the 
annualized (per year) costs of Norplant may be significantly higher in some 
women. With a first year removal rate in the range of 20%, many women do 
not achieve the five years of contraception promoted to them by Wyeth. With 
the costs of difficult surgical removal of the implant, or administration of 
additional drugs, e.g., estrogens or combination oral contraceptives, to remedy 
Norplant side effects 12-14, the yearly cost of Norplant may actually surpass that 
of oral contraceptives. These hidden costs are not factored into Wyeth's 
idealized cost estimates for Norplant use.33 
Coercive and Deceptive Use of Norplant 
Less than one month after Norplant's U.S. licensing a California judge 
sentenced a 27-year-old pregnant mother of four children to have the birth 
control rods implanted as part of a criminal sentence for beating two of her 
children.37 Three months after the sentence this judge, who prided himself on 
"creative sentencing"38, removed himselffrom the case due to the nationwide 
attention, including an American Civil Liberties Union supported appeal,39-46 
Later that year a Texasjudge ordered a 23-year-old woman to use Norplant 
after her baby was born with methad'one in his blood.47 
This sort of "creative sentencing" prompted several state legislatures to 
discuss financial incentives for women on welfare to use Norplant, or make 
welfare contingent on Norplant use.48-53 A bill was even introduced in Ohio 
which would have required Norplant or tubal ligation for women, or 
vasectomy for men, if the family had a child and received welfare benefits for 
their support. Parents would have faced jail for refusing sterilization or 
Norplant.54 
The American Medical Association decried this government pressure, 
stating, "Court-ordered use of long-acting contraceptives ... raises serious 
questions about a person's fundamental right to refuse medical treatment, to be 
free of cruel and unusual punishment, and to procreate." The AMA also 
asserted, "Government benefits should not be made contingent on the 
acceptance of a health risk."55 
This U.S. coercion reflects several foreign pre-licensing studies, where 
women were not properly warned of Norplant-associated risks, or were refused 
removal of the rods when requested. 56-59 
Concerns were also expressed that Indonesian medical authorities do not 
know the identities of women with Norplant who are due for its removal. The 
chance of ectopic pregnancy is reported to increase if the rods are not removed 
after five years, resulting in possible Fallopian tube rupture with potential fatal 
internal hemorrhage. These women are called "walking time bombs," because 
many live in remote areas lacking medical care.60 
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Difficulty in Norplant Removal and Class Action Lawsuit 
As expected, based on experience with other contraceptives,61 a class action 
lawsuit was filed September 13, 1993 in Illinois on behalf of women severely or 
permanently injured by Norplant. The amended complaint, filed on November 
5, 1993, alleges that the manufacturer failed to warn "about the difficulty of 
(NORPLANT) removal," and as a result, women " ... were damaged . .. and ... 
will require continuing medical care due . . . to the difficulty with removal of 
Norplant."62 
The complaint details the unfavorable experiences of four women with 
Norplant. One woman suffered "interrupted and/or heavy and continual 
menstrual flow, nausea, weight gain (20 pounds), and severe headaches." Sixteen 
months after Norplant insertion, the physician, who unsuccessfully attempted to 
remove the rods, closed the incision and told her to return again. Three months 
later, and after two additional failed attempts to remove the rods, she was forced 
"to undergo surgery, under a general anesthetic .. . to remove the Norplant 
implants," and now "has severe scarring ... " 
A second woman gained eighteen pounds, developed menstrual irregularities, 
excessive hair growth, acne, and emotional side effects (irritability) during her 
thirteen-month use of Norplant. The more than two-hour implant removal 
surgery required two separate incisions. Her arm was "bruised and sore," and" ... 
left with two ugly scars." She continues to consult a dermatologist for the acne. 
During a third woman's seventeen months on Norplant she "experienced 
abnormally long menstrual cycles," which progressed to lack of menstrual 
cycles," which progressed to lack of menstrual cycles, " .. . hot flashes, headaches, 
and a numbness and pain in her left arm" so severe that "she could not pick things 
up with her left hand . .. " Although she sought removal of the Norplant rods 
fifteen months after insertion, doctors were unsuccessful in removing them, even 
after nearly Ilh hours of surgery. Two months later two more surgeons finally 
removed the implants through two separate incisions. She now has "severe 
scarring" after the two painful removal surgeries. 
A fourth woman's Norplant experience included "excessive bleeding for two 
weeks" (after insertion), with "nausea, dizziness, weight gain, . .. migraine 
headaches, diminished sex drive, (and) ... irritability" for the thirteen months the 
Norplant rods were in her body. Four months after insertion she complained to 
her doctor about the side effects, and was told twice to wait for two months (an 
additional four months). She finally demanded removal of the Norplant rods ten 
months after they were inserted. 
Dependent on public assistance she was told that the clinic lacked government 
funds for Norplant removal, and to wait three more months until the next fiscal 
year. During these three months she failed to find a physician who would remove 
the implants. When government funds became available, she returned to the 
clinic and underwent llh hours of surgery to remove only two of the six implants. 
The nexy month she endured three more surgeries, one lasting 3lh hours with 
eight injections of anesthetic, yielding removal of only one implant. Another 
surgical attempt failed to remove any of the three remaining implants. She was 
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referred to a specialist who recommended surgery under general anesthesia. 
Nearly five months after asking for Norplant removal, the fourth surgery removed 
the remaining three implants. She now has "severe scarring" and arm pain. 
The suit accuses Norplant's manufacturer, Wyeth-Ayerst, of nine charges, 
induding "negligence" and "consumer fraud," asks that Wyeth improve its 
warnings to women, and devise a "sufficient training program" for those who 
insert Norplant. The plaintiffs ask that a compensation fund be established for 
these and other women (similar to the funds established several years ago for 
women damaged by intrauterine devices 63- 66 and recently proposed for women 
damaged by silicone gel breast implants67). 
Considering that the approximately 800,000 U.S. women who currently use 
Norplant will ultimately seek removal of the implants, it is unknown how many 
other women will experience problems similar to those in the lawsuit. One could 
reasonably expect that the longer the implants are in place, the more difficult they 
might be to remove due to adhesions and scar tissue formation. In fact, it has been 
recommended that when the implants can not be felt in the woman's arm, or they 
migrate to deeper tissues, x-ray or ultrasound be employed to help locate the 
Norplant rods.68 
At a 1993 contraception conference a Planned Parenthood physician reported 
that insertion of Norplant rods is usually uncomplicated, but some health care 
providers have expressed difficulty in removing them. An obstetrics and 
gynecology professor recommended use of a curved hemostat to "vigorously 
break up" adhesions.69 
Conclusion 
Three years of use in the United States has uncovered the hidden side of 
Norplant. Nearly all Norplant users will experience side effects, forcing early 
implant removal in about one-fifth of them during the first year alone. Implant 
removal is difficult in some women, possibly involving multiple prolonged 
surgical attempts, induding surgery under general anesthesia, leaving unsightly 
scars. In addition, Norplant has not proven to be the solution to the moral and 
social problem of teenage out-of-wedlock pregnancy, as was predicted, nor does 
it protect against STD's. For many women Norplant has been a disappointment, 
if not an abject failure. 
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